why choose us

First received: April 14, 2023

Clinical Trial: A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pneumococcal Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind Study of the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine With a Novel Adjuvant Administered in Adults 50 Through 64 Years of Age

Brief Summary: The purpose of this clinical trial is to learn about a pneumococcal vaccine with a new ingredient (PF-07872411) intended to enhance the effects of the vaccine.This pneumococcal vaccine with the new ingredient may prevent the diseases caused by pneumococcal bacteria like meningitis, sepsis, ear infections and sinusitis.Meningitis is an infection in which the tissue around the brain and spine is swollen.Sepsis is a very serious infection in your blood caused by a germ (a bacteria).Sinusitis is when your sinuses (the…

Read more